Share Price and Basic Stock Data
Last Updated: October 10, 2025, 1:51 am
| PEG Ratio | -0.11 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Mysore Petro Chemicals Ltd operates within the organic chemicals sector, specifically focusing on maleic anhydride. As of the latest reporting, the company’s stock price stood at ₹118, with a market capitalization of ₹77.8 Cr. Revenue trends indicate significant volatility; sales reached ₹1.45 Cr in June 2022, peaking at ₹15.18 Cr in March 2024 before declining to ₹7.44 Cr in March 2025. The trailing twelve months (TTM) sales were recorded at ₹30.25 Cr. This indicates a recovery phase after a dip, with the company’s performance in recent quarters showing oscillation, particularly with a zero revenue recorded in June 2023. The sales growth during FY 2025 is notable, with a forecasted increase in sales compared to FY 2024, where they recorded ₹25.80 Cr. The company’s operational efficiency, however, is impeded by high expenses, which reached ₹39.07 Cr in FY 2025, reflecting the challenging dynamics in the chemical industry.
Profitability and Efficiency Metrics
Profitability metrics for Mysore Petro Chemicals Ltd reveal an ongoing struggle with operational profitability. The operating profit margin (OPM) was reported at -33.06% for FY 2025, a stark contrast to the industry norms that typically hover around positive margins. The company recorded a net profit of ₹3.04 Cr for FY 2025, a decline from ₹7.47 Cr in FY 2024, indicating potential issues in cost management and pricing strategies. Return on equity (ROE) and return on capital employed (ROCE) stood at 1.30% and 7.82%, respectively, both notably low compared to industry standards, suggesting inefficient capital utilization. Furthermore, the interest coverage ratio (ICR) is exceptionally high at 62.63x, indicating that the company can comfortably cover its interest obligations, despite the operational losses. The cash conversion cycle, at 86.45 days, reflects delays in converting investments into cash, which could hinder liquidity and operational flexibility.
Balance Sheet Strength and Financial Ratios
The balance sheet of Mysore Petro Chemicals Ltd shows a conservative borrowing strategy, with total borrowings reported at just ₹0.22 Cr against reserves of ₹214.10 Cr. This translates into a low debt-to-equity ratio, signifying financial prudence in leveraging. The company’s current ratio, reported at 3.98, indicates robust liquidity, suggesting that it can meet short-term obligations effectively. However, the quick ratio, also at 3.98, confirms that this liquidity is not overly reliant on inventory, which stood at zero. Financial ratios such as price-to-book value (P/BV) at 0.37x indicate that the stock may be undervalued relative to its book value, potentially appealing to value investors. Additionally, the net profit margin was recorded at -33.86% for FY 2025, underscoring the need for operational improvements to enhance profitability. Overall, while the balance sheet reflects strength in liquidity and low debt, profitability remains a concern.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Mysore Petro Chemicals Ltd reveals a dominant promoter holding of 72.99%, indicating strong control by the founding family. This level of promoter confidence may positively influence investor sentiment. Institutional ownership remains minimal, with foreign institutional investors (FIIs) holding 3.03% and domestic institutional investors (DIIs) at 0.44%. Public ownership stands at 23.53%, with a total of 5,774 shareholders as of March 2025. The stability in promoter and public shareholding suggests a level of confidence in the company’s long-term prospects despite recent operational challenges. The trends show a slight increase in FII participation from 0% in previous quarters, which could indicate growing interest from foreign investors. However, the overall low institutional holding could also reflect skepticism about the company’s ability to deliver consistent profitability and growth, potentially impacting stock liquidity and market perception.
Outlook, Risks, and Final Insight
If margins sustain improvements and the company successfully implements cost-control measures, Mysore Petro Chemicals Ltd could see enhanced profitability and operational stability. However, risks remain, including ongoing volatility in sales and the potential for operational inefficiencies to persist. The high levels of expenses relative to sales and negative profit margins challenge the company’s long-term viability unless addressed effectively. Additionally, the reliance on a concentrated promoter holding could pose risks if market sentiment shifts negatively. Conversely, if the company can leverage its strong liquidity position and low debt levels to invest in operational efficiencies or product development, it may turn around its financial performance. Stakeholders should closely monitor sales trends and expense management strategies to gauge the efficacy of management in navigating these challenges.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Mysore Petro Chemicals Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Mysore Petro Chemicals Ltd | 77.3 Cr. | 117 | 242/111 | 5.95 | 335 | 1.70 % | 7.82 % | 1.30 % | 10.0 |
| I G Petrochemicals Ltd | 1,323 Cr. | 429 | 660/361 | 19.2 | 431 | 2.33 % | 11.4 % | 8.53 % | 10.0 |
| Industry Average | 1,323.00 Cr | 273.00 | 12.58 | 383.00 | 2.02% | 9.61% | 4.92% | 10.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.45 | 8.33 | 2.18 | 6.46 | 0.00 | 7.08 | 5.79 | 15.18 | 13.89 | 9.16 | 6.39 | 7.44 | 7.26 |
| Expenses | 3.71 | 8.99 | 3.76 | 10.65 | 1.54 | 7.78 | 8.69 | 18.92 | 18.44 | 10.64 | 7.59 | 8.04 | 9.66 |
| Operating Profit | -2.26 | -0.66 | -1.58 | -4.19 | -1.54 | -0.70 | -2.90 | -3.74 | -4.55 | -1.48 | -1.20 | -0.60 | -2.40 |
| OPM % | -155.86% | -7.92% | -72.48% | -64.86% | -9.89% | -50.09% | -24.64% | -32.76% | -16.16% | -18.78% | -8.06% | -33.06% | |
| Other Income | 11.95 | 8.64 | 6.60 | 9.42 | 8.72 | 3.07 | 3.03 | 4.48 | 19.59 | 0.38 | -7.80 | 4.01 | 2.36 |
| Interest | 0.12 | 0.19 | 0.12 | 0.16 | 0.04 | 0.01 | 0.03 | 0.20 | 0.40 | 0.02 | 0.02 | 0.02 | 0.02 |
| Depreciation | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 | 0.46 | 1.00 | 0.09 | 0.09 | 0.09 | 0.09 |
| Profit before tax | 9.46 | 7.68 | 4.79 | 4.96 | 7.03 | 2.25 | -0.01 | 0.08 | 13.64 | -1.21 | -9.11 | 3.30 | -0.15 |
| Tax % | 25.05% | 17.19% | 18.58% | 32.06% | 25.60% | -3.11% | 200.00% | 925.00% | 35.78% | 107.44% | -31.83% | 31.52% | 166.67% |
| Net Profit | 7.08 | 6.37 | 3.90 | 3.37 | 5.23 | 2.32 | -0.03 | -0.67 | 8.75 | -2.51 | -6.21 | 2.26 | -0.40 |
| EPS in Rs | 10.75 | 9.68 | 5.92 | 5.12 | 7.94 | 3.52 | -0.05 | -0.08 | 14.43 | -3.81 | -9.43 | 3.43 | -0.61 |
Last Updated: August 19, 2025, 1:15 pm
Below is a detailed analysis of the quarterly data for Mysore Petro Chemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 7.26 Cr.. The value appears to be declining and may need further review. It has decreased from 7.44 Cr. (Mar 2025) to 7.26 Cr., marking a decrease of 0.18 Cr..
- For Expenses, as of Jun 2025, the value is 9.66 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8.04 Cr. (Mar 2025) to 9.66 Cr., marking an increase of 1.62 Cr..
- For Operating Profit, as of Jun 2025, the value is -2.40 Cr.. The value appears to be declining and may need further review. It has decreased from -0.60 Cr. (Mar 2025) to -2.40 Cr., marking a decrease of 1.80 Cr..
- For OPM %, as of Jun 2025, the value is -33.06%. The value appears to be declining and may need further review. It has decreased from -8.06% (Mar 2025) to -33.06%, marking a decrease of 25.00%.
- For Other Income, as of Jun 2025, the value is 2.36 Cr.. The value appears to be declining and may need further review. It has decreased from 4.01 Cr. (Mar 2025) to 2.36 Cr., marking a decrease of 1.65 Cr..
- For Interest, as of Jun 2025, the value is 0.02 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.02 Cr..
- For Depreciation, as of Jun 2025, the value is 0.09 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.09 Cr..
- For Profit before tax, as of Jun 2025, the value is -0.15 Cr.. The value appears to be declining and may need further review. It has decreased from 3.30 Cr. (Mar 2025) to -0.15 Cr., marking a decrease of 3.45 Cr..
- For Tax %, as of Jun 2025, the value is 166.67%. The value appears to be increasing, which may not be favorable. It has increased from 31.52% (Mar 2025) to 166.67%, marking an increase of 135.15%.
- For Net Profit, as of Jun 2025, the value is -0.40 Cr.. The value appears to be declining and may need further review. It has decreased from 2.26 Cr. (Mar 2025) to -0.40 Cr., marking a decrease of 2.66 Cr..
- For EPS in Rs, as of Jun 2025, the value is -0.61. The value appears to be declining and may need further review. It has decreased from 3.43 (Mar 2025) to -0.61, marking a decrease of 4.04.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 23, 2025, 12:53 pm
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 30.30 | 6.23 | 32.58 | 12.98 | 22.84 | 20.90 | 18.41 | 25.80 | 33.48 | 30.25 |
| Expenses | 24.60 | 9.79 | 35.95 | 15.53 | 24.98 | 23.65 | 25.55 | 30.25 | 39.07 | 35.93 |
| Operating Profit | 5.70 | -3.56 | -3.37 | -2.55 | -2.14 | -2.75 | -7.14 | -4.45 | -5.59 | -5.68 |
| OPM % | 18.81% | -57.14% | -10.34% | -19.65% | -9.37% | -13.16% | -38.78% | -17.25% | -16.70% | -18.78% |
| Other Income | 13.98 | 93.03 | 22.59 | 8.64 | 27.00 | 46.19 | 35.05 | 14.98 | 13.39 | -1.05 |
| Interest | 1.20 | 0.07 | 0.04 | 0.06 | 0.34 | 0.26 | 0.58 | 0.12 | 0.07 | 0.08 |
| Depreciation | 2.93 | 0.78 | 0.68 | 0.63 | 0.60 | 0.59 | 0.43 | 0.45 | 0.37 | 0.36 |
| Profit before tax | 15.55 | 88.62 | 18.50 | 5.40 | 23.92 | 42.59 | 26.90 | 9.96 | 7.36 | -7.17 |
| Tax % | 5.59% | 19.15% | 4.00% | 10.00% | 109.32% | 23.24% | 22.97% | 25.00% | 58.70% | |
| Net Profit | 14.68 | 71.65 | 17.76 | 4.86 | -2.24 | 32.69 | 20.72 | 7.47 | 3.04 | -6.86 |
| EPS in Rs | 22.30 | 108.83 | 26.98 | 7.38 | -3.40 | 49.65 | 31.47 | 11.35 | 4.62 | -10.42 |
| Dividend Payout % | 4.49% | 1.84% | 7.42% | 27.12% | -58.84% | 5.04% | 7.95% | 22.05% | 43.36% |
YoY Net Profit Growth
| Year | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 388.08% | -75.21% | -72.64% | -146.09% | 1559.38% | -36.62% | -63.95% | -59.30% |
| Change in YoY Net Profit Growth (%) | 0.00% | -463.29% | 2.58% | -73.46% | 1705.47% | -1595.99% | -27.33% | 4.64% |
Mysore Petro Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2017-2018 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 21% |
| 3 Years: | 17% |
| TTM: | -28% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -9% |
| 3 Years: | -55% |
| TTM: | 223% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 19% |
| 3 Years: | 2% |
| 1 Year: | -47% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 6% |
| 3 Years: | 4% |
| Last Year: | 1% |
Last Updated: September 5, 2025, 3:46 pm
Balance Sheet
Last Updated: July 25, 2025, 1:02 pm
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.59 | 6.59 | 6.59 | 6.59 | 6.59 | 6.59 | 6.59 | 6.59 | 6.59 |
| Reserves | 69.65 | 140.67 | 156.89 | 160.12 | 156.67 | 187.98 | 207.09 | 213.66 | 214.10 |
| Borrowings | 6.17 | 0.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 20.31 | 0.22 |
| Other Liabilities | 10.47 | 4.66 | 5.97 | 6.11 | 30.88 | 39.59 | 44.64 | 63.60 | 52.03 |
| Total Liabilities | 92.88 | 152.24 | 169.45 | 172.82 | 194.14 | 234.16 | 258.32 | 304.16 | 272.94 |
| Fixed Assets | 32.50 | 18.83 | 16.30 | 15.67 | 15.07 | 15.77 | 15.34 | 47.51 | 14.50 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.30 | 2.02 | 0.00 |
| Investments | 53.95 | 79.42 | 107.18 | 115.48 | 144.94 | 213.33 | 227.90 | 231.64 | 241.55 |
| Other Assets | 6.43 | 53.99 | 45.97 | 41.67 | 34.13 | 5.06 | 14.78 | 22.99 | 16.89 |
| Total Assets | 92.88 | 152.24 | 169.45 | 172.82 | 194.14 | 234.16 | 258.32 | 304.16 | 272.94 |
Below is a detailed analysis of the balance sheet data for Mysore Petro Chemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 6.59 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 6.59 Cr..
- For Reserves, as of Mar 2025, the value is 214.10 Cr.. The value appears strong and on an upward trend. It has increased from 213.66 Cr. (Mar 2024) to 214.10 Cr., marking an increase of 0.44 Cr..
- For Borrowings, as of Mar 2025, the value is 0.22 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 20.31 Cr. (Mar 2024) to 0.22 Cr., marking a decrease of 20.09 Cr..
- For Other Liabilities, as of Mar 2025, the value is 52.03 Cr.. The value appears to be improving (decreasing). It has decreased from 63.60 Cr. (Mar 2024) to 52.03 Cr., marking a decrease of 11.57 Cr..
- For Total Liabilities, as of Mar 2025, the value is 272.94 Cr.. The value appears to be improving (decreasing). It has decreased from 304.16 Cr. (Mar 2024) to 272.94 Cr., marking a decrease of 31.22 Cr..
- For Fixed Assets, as of Mar 2025, the value is 14.50 Cr.. The value appears to be declining and may need further review. It has decreased from 47.51 Cr. (Mar 2024) to 14.50 Cr., marking a decrease of 33.01 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2.02 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 2.02 Cr..
- For Investments, as of Mar 2025, the value is 241.55 Cr.. The value appears strong and on an upward trend. It has increased from 231.64 Cr. (Mar 2024) to 241.55 Cr., marking an increase of 9.91 Cr..
- For Other Assets, as of Mar 2025, the value is 16.89 Cr.. The value appears to be declining and may need further review. It has decreased from 22.99 Cr. (Mar 2024) to 16.89 Cr., marking a decrease of 6.10 Cr..
- For Total Assets, as of Mar 2025, the value is 272.94 Cr.. The value appears to be declining and may need further review. It has decreased from 304.16 Cr. (Mar 2024) to 272.94 Cr., marking a decrease of 31.22 Cr..
Notably, the Reserves (214.10 Cr.) exceed the Borrowings (0.22 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -0.47 | -3.88 | -3.37 | -2.55 | -2.14 | -2.75 | -7.14 | -24.76 | -5.81 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 19.76 | 0.00 | 4.37 | 20.53 | 77.67 | 29.34 | 104.09 | 137.79 | 86.45 |
| Inventory Days | 146.83 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 27.01 | 0.00 |
| Days Payable | 149.60 | 26.12 | |||||||
| Cash Conversion Cycle | 16.99 | 0.00 | 4.37 | 20.53 | 77.67 | 29.34 | 104.09 | 138.68 | 86.45 |
| Working Capital Days | -45.66 | 642.12 | 138.92 | 410.84 | 290.37 | -6.46 | 81.88 | -84.74 | 28.67 |
| ROCE % | 20.91% | 11.47% | 3.12% | 18.92% | 23.58% | 12.26% | 4.94% | 7.82% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 4.62 | 11.35 | 31.48 | 49.66 | -3.41 |
| Diluted EPS (Rs.) | 4.62 | 11.35 | 31.48 | 49.66 | -3.41 |
| Cash EPS (Rs.) | -16.65 | 3.67 | -8.06 | -2.59 | -29.73 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 335.00 | 337.31 | 324.36 | 295.36 | 247.83 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 335.00 | 337.31 | 324.36 | 295.36 | 247.83 |
| Revenue From Operations / Share (Rs.) | 50.82 | 42.58 | 27.95 | 31.73 | 34.67 |
| PBDIT / Share (Rs.) | 6.53 | 7.88 | 2.20 | 12.82 | -0.04 |
| PBIT / Share (Rs.) | 5.97 | 6.67 | 1.55 | 11.92 | -0.95 |
| PBT / Share (Rs.) | 6.20 | 6.24 | 0.66 | 11.53 | -1.48 |
| Net Profit / Share (Rs.) | -17.21 | 2.46 | -8.71 | -3.49 | -41.18 |
| NP After MI And SOA / Share (Rs.) | 4.62 | 11.34 | 31.45 | 49.63 | -3.40 |
| PBDIT Margin (%) | 12.85 | 18.51 | 7.87 | 40.41 | -0.13 |
| PBIT Margin (%) | 11.75 | 15.66 | 5.55 | 37.56 | -2.76 |
| PBT Margin (%) | 12.19 | 14.64 | 2.38 | 36.34 | -4.25 |
| Net Profit Margin (%) | -33.86 | 5.77 | -31.17 | -11.01 | -118.78 |
| NP After MI And SOA Margin (%) | 9.09 | 26.63 | 112.53 | 156.42 | -9.82 |
| Return on Networth / Equity (%) | 1.37 | 3.39 | 9.69 | 16.80 | -1.37 |
| Return on Capital Employeed (%) | 1.47 | 1.55 | 0.40 | 3.39 | -0.33 |
| Return On Assets (%) | 1.11 | 2.45 | 8.02 | 13.96 | -1.15 |
| Asset Turnover Ratio (%) | 0.11 | 0.09 | 0.10 | 0.14 | 0.17 |
| Current Ratio (X) | 3.98 | 1.41 | 13.06 | 7.26 | 8.24 |
| Quick Ratio (X) | 3.98 | 1.33 | 13.06 | 7.26 | 8.24 |
| Inventory Turnover Ratio (X) | 36.58 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 54.08 | 22.02 | 7.94 | 4.02 | -58.68 |
| Dividend Payout Ratio (CP) (%) | 48.23 | 19.89 | 7.78 | 3.95 | 24.82 |
| Earning Retention Ratio (%) | 45.92 | 77.98 | 92.06 | 95.98 | 158.68 |
| Cash Earning Retention Ratio (%) | 51.77 | 80.11 | 92.22 | 96.05 | 75.18 |
| Interest Coverage Ratio (X) | 62.63 | 18.20 | 2.49 | 32.94 | -0.08 |
| Interest Coverage Ratio (Post Tax) (X) | -5.62 | 6.68 | -8.84 | -7.98 | -78.58 |
| Enterprise Value (Cr.) | 75.36 | 112.03 | 65.88 | 67.57 | 47.69 |
| EV / Net Operating Revenue (X) | 2.25 | 3.99 | 3.58 | 3.23 | 2.09 |
| EV / EBITDA (X) | 17.51 | 21.57 | 45.45 | 8.00 | -1563.51 |
| MarketCap / Net Operating Revenue (X) | 2.44 | 4.13 | 3.97 | 3.28 | 2.17 |
| Retention Ratios (%) | 45.91 | 77.97 | 92.05 | 95.97 | 158.68 |
| Price / BV (X) | 0.37 | 0.52 | 0.34 | 0.35 | 0.30 |
| Price / Net Operating Revenue (X) | 2.44 | 4.13 | 3.97 | 3.28 | 2.17 |
| EarningsYield | 0.03 | 0.06 | 0.28 | 0.47 | -0.04 |
After reviewing the key financial ratios for Mysore Petro Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 4.62. This value is below the healthy minimum of 5. It has decreased from 11.35 (Mar 24) to 4.62, marking a decrease of 6.73.
- For Diluted EPS (Rs.), as of Mar 25, the value is 4.62. This value is below the healthy minimum of 5. It has decreased from 11.35 (Mar 24) to 4.62, marking a decrease of 6.73.
- For Cash EPS (Rs.), as of Mar 25, the value is -16.65. This value is below the healthy minimum of 3. It has decreased from 3.67 (Mar 24) to -16.65, marking a decrease of 20.32.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 335.00. It has decreased from 337.31 (Mar 24) to 335.00, marking a decrease of 2.31.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 335.00. It has decreased from 337.31 (Mar 24) to 335.00, marking a decrease of 2.31.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 50.82. It has increased from 42.58 (Mar 24) to 50.82, marking an increase of 8.24.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 6.53. This value is within the healthy range. It has decreased from 7.88 (Mar 24) to 6.53, marking a decrease of 1.35.
- For PBIT / Share (Rs.), as of Mar 25, the value is 5.97. This value is within the healthy range. It has decreased from 6.67 (Mar 24) to 5.97, marking a decrease of 0.70.
- For PBT / Share (Rs.), as of Mar 25, the value is 6.20. This value is within the healthy range. It has decreased from 6.24 (Mar 24) to 6.20, marking a decrease of 0.04.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -17.21. This value is below the healthy minimum of 2. It has decreased from 2.46 (Mar 24) to -17.21, marking a decrease of 19.67.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 4.62. This value is within the healthy range. It has decreased from 11.34 (Mar 24) to 4.62, marking a decrease of 6.72.
- For PBDIT Margin (%), as of Mar 25, the value is 12.85. This value is within the healthy range. It has decreased from 18.51 (Mar 24) to 12.85, marking a decrease of 5.66.
- For PBIT Margin (%), as of Mar 25, the value is 11.75. This value is within the healthy range. It has decreased from 15.66 (Mar 24) to 11.75, marking a decrease of 3.91.
- For PBT Margin (%), as of Mar 25, the value is 12.19. This value is within the healthy range. It has decreased from 14.64 (Mar 24) to 12.19, marking a decrease of 2.45.
- For Net Profit Margin (%), as of Mar 25, the value is -33.86. This value is below the healthy minimum of 5. It has decreased from 5.77 (Mar 24) to -33.86, marking a decrease of 39.63.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 9.09. This value is within the healthy range. It has decreased from 26.63 (Mar 24) to 9.09, marking a decrease of 17.54.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.37. This value is below the healthy minimum of 15. It has decreased from 3.39 (Mar 24) to 1.37, marking a decrease of 2.02.
- For Return on Capital Employeed (%), as of Mar 25, the value is 1.47. This value is below the healthy minimum of 10. It has decreased from 1.55 (Mar 24) to 1.47, marking a decrease of 0.08.
- For Return On Assets (%), as of Mar 25, the value is 1.11. This value is below the healthy minimum of 5. It has decreased from 2.45 (Mar 24) to 1.11, marking a decrease of 1.34.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.11. It has increased from 0.09 (Mar 24) to 0.11, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 3.98. This value exceeds the healthy maximum of 3. It has increased from 1.41 (Mar 24) to 3.98, marking an increase of 2.57.
- For Quick Ratio (X), as of Mar 25, the value is 3.98. This value exceeds the healthy maximum of 2. It has increased from 1.33 (Mar 24) to 3.98, marking an increase of 2.65.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 36.58. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 36.58, marking an increase of 36.58.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 54.08. This value exceeds the healthy maximum of 50. It has increased from 22.02 (Mar 24) to 54.08, marking an increase of 32.06.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 48.23. This value is within the healthy range. It has increased from 19.89 (Mar 24) to 48.23, marking an increase of 28.34.
- For Earning Retention Ratio (%), as of Mar 25, the value is 45.92. This value is within the healthy range. It has decreased from 77.98 (Mar 24) to 45.92, marking a decrease of 32.06.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 51.77. This value is within the healthy range. It has decreased from 80.11 (Mar 24) to 51.77, marking a decrease of 28.34.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 62.63. This value is within the healthy range. It has increased from 18.20 (Mar 24) to 62.63, marking an increase of 44.43.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -5.62. This value is below the healthy minimum of 3. It has decreased from 6.68 (Mar 24) to -5.62, marking a decrease of 12.30.
- For Enterprise Value (Cr.), as of Mar 25, the value is 75.36. It has decreased from 112.03 (Mar 24) to 75.36, marking a decrease of 36.67.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.25. This value is within the healthy range. It has decreased from 3.99 (Mar 24) to 2.25, marking a decrease of 1.74.
- For EV / EBITDA (X), as of Mar 25, the value is 17.51. This value exceeds the healthy maximum of 15. It has decreased from 21.57 (Mar 24) to 17.51, marking a decrease of 4.06.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.44. This value is within the healthy range. It has decreased from 4.13 (Mar 24) to 2.44, marking a decrease of 1.69.
- For Retention Ratios (%), as of Mar 25, the value is 45.91. This value is within the healthy range. It has decreased from 77.97 (Mar 24) to 45.91, marking a decrease of 32.06.
- For Price / BV (X), as of Mar 25, the value is 0.37. This value is below the healthy minimum of 1. It has decreased from 0.52 (Mar 24) to 0.37, marking a decrease of 0.15.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.44. This value is within the healthy range. It has decreased from 4.13 (Mar 24) to 2.44, marking a decrease of 1.69.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 24) to 0.03, marking a decrease of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Mysore Petro Chemicals Ltd:
- Net Profit Margin: -33.86%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 1.47% (Industry Average ROCE: 9.61%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.37% (Industry Average ROE: 4.92%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -5.62
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.98
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 5.95 (Industry average Stock P/E: 12.58)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -33.86%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Maleic Anhydride | D/4, Jyothi Complex, 134/1, Infantry Road, Bengaluru Karnataka 560001 | mpcl@mysorepetro.com http://www.mysorepetro.com |
| Management | |
|---|---|
| Name | Position Held |
| Dr. Vaijayanti Pandit | Chairperson & Independent Director |
| Mr. Nikunj Dhanuka | Non Executive Director |
| Mr. Mayank Dhanuka | Non Executive Director |
| Mr. Satyanarayan Bankatlal Maheshwari | Executive Director |
| Mr. Shanti Kumar Loonker | Independent Director |
| Mrs. Uma Acharya | Independent Director |
FAQ
What is the intrinsic value of Mysore Petro Chemicals Ltd?
Mysore Petro Chemicals Ltd's intrinsic value (as of 09 October 2025) is 21.08 which is 81.98% lower the current market price of 117.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹77.3 Cr. market cap, FY2025-2026 high/low of 242/111, reserves of ₹214.10 Cr, and liabilities of 272.94 Cr.
What is the Market Cap of Mysore Petro Chemicals Ltd?
The Market Cap of Mysore Petro Chemicals Ltd is 77.3 Cr..
What is the current Stock Price of Mysore Petro Chemicals Ltd as on 09 October 2025?
The current stock price of Mysore Petro Chemicals Ltd as on 09 October 2025 is 117.
What is the High / Low of Mysore Petro Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Mysore Petro Chemicals Ltd stocks is 242/111.
What is the Stock P/E of Mysore Petro Chemicals Ltd?
The Stock P/E of Mysore Petro Chemicals Ltd is 5.95.
What is the Book Value of Mysore Petro Chemicals Ltd?
The Book Value of Mysore Petro Chemicals Ltd is 335.
What is the Dividend Yield of Mysore Petro Chemicals Ltd?
The Dividend Yield of Mysore Petro Chemicals Ltd is 1.70 %.
What is the ROCE of Mysore Petro Chemicals Ltd?
The ROCE of Mysore Petro Chemicals Ltd is 7.82 %.
What is the ROE of Mysore Petro Chemicals Ltd?
The ROE of Mysore Petro Chemicals Ltd is 1.30 %.
What is the Face Value of Mysore Petro Chemicals Ltd?
The Face Value of Mysore Petro Chemicals Ltd is 10.0.